AMI Cardiogenic Shock

The Procedure

 

Good Outcomes in Cardiogenic Shock are Associated with:

  • Early shock recognition1
  • Initiation of Impella® device support pre-PCI
  • Use of right heart catheterization (RHC) to optimize therapy1
  • Timely escalation of care

Unloading Pre-PCI Associated with Improved AMI Cardiogenic Shock Outcome

The following charts provides compelling evidence that pre-PCI unloading is associated with higher survival rates in AMI cardiogenic shock. The consistent trend across multiple studies and large sample sizes strengthens the validity of these findings. Significant p-values in most studies further emphasize the reliability of the results.

Key Chart Observations

  • Pre-PCI Survival Rates: Generally higher survival rates across all studies.
  • Post-PCI Survival Rates: Tend to be lower compared to Pre-PCI rates.
  • Matched Control Groups: Where included, often have the lowest survival rates, indicating the benefit of intervention.
  • p-Values: Most studies show statistically significant differences (p < 0.05).
Unloading Pre-PCI Associated with Improved AMI Cardiogenic Shock Outcome Unloading Pre-PCI Associated with Improved AMI Cardiogenic Shock Outcome

Right Heart Failure Right Heart Failure

Right Heart Failure is Common in AMI Cardiogenic Shock and Associated with a Three-Fold Increase in Mortality

It is important to identify right heart dysfunction early and before the patient leaves the cath lab.

Differential Utilization of Impella Devices, ECMO, and Combined Therapies as Escalation and De-escalation Strategies Differential Utilization of Impella Devices, ECMO, and Combined Therapies as Escalation and De-escalation Strategies

Differential Utilization of Impella Devices, ECMO, and Combined Therapies as Escalation and De-escalation Strategies

“The decision to escalate, de-escalate or wean is highly dependent on patient presentation, capabilities of the institution, and the expertise of the heart team,” write the authors of this paper on differential usage of Impella devices, extracorporeal membrane oxygenation (ECMO), and combined strategies in patients with cardiogenic shock.

 

Escalation and De-escalation Strategies

Alexander Bernhardt, M.D., discusses insertion, escalation, de-escalation, and weaning of mechanical circulatory support (MCS) devices in patients with cardiogenic shock.

Right Heart Failure Right Heart Failure

Step-by-Step Axillary Insertion - Impella 5.5® with SmartAssist® Heart Pump

Discover our step-by-step instruction for the axillary insertion of the Impella 5.5 with SmartAssist.

Differential Utilization of Impella Devices, ECMO, and Combined Therapies as Escalation and De-escalation Strategies

Step-by-Step Direct Aortic Insertion - Impella 5.5® with SmartAssist® Heart Pump

Discover our step-by-step instruction for the direct aortic insertion of the Impella 5.5 with SmartAssist.

 

Early Left Ventricular Unloading Improves Survival in Patients in Cardiogenic Shock - Supported by Extracorporeal Membrane Oxygenation (ECMO)

New research shows that early left ventricular unloading with Impella heart pumps improves survival in patients with cardiogenic shock supported by extracorporeal membrane oxygenation (ECMO).

References

  1. O'Neill, W.W., TCT 2020.

NPS-2629

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].